Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
about
A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease.Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.LABA/LAMA fixed-dose combinations in patients with COPD: a systematic reviewDual bronchodilation vs triple therapy in the "real-life" COPD DACCORD studyNew developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
P2860
Q33736509-EFE86F5F-D4BD-4A0F-B583-7BB0689EA61FQ38608618-50CE9167-5FBD-48C6-B1EC-602B3B693962Q39426952-00E91AB8-B613-4266-BBC3-E76FBF06C0F7Q47159721-275BF052-6FD8-47C6-815E-CF385B9EA7C7Q52564740-1C057BC4-FAA4-4626-9AC1-14864BCE4D69Q57483685-833FF116-518C-4822-B64A-B65FCA5027BBQ58706049-F29ECF72-C219-4FF7-A678-7F0463ADB6DEQ58759101-9B6A6F8F-F172-4D16-B210-C76D214F808B
P2860
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Long-acting muscarinic antagon ...... tive pulmonary disease (COPD).
@ast
Long-acting muscarinic antagon ...... tive pulmonary disease (COPD).
@en
type
label
Long-acting muscarinic antagon ...... tive pulmonary disease (COPD).
@ast
Long-acting muscarinic antagon ...... tive pulmonary disease (COPD).
@en
prefLabel
Long-acting muscarinic antagon ...... tive pulmonary disease (COPD).
@ast
Long-acting muscarinic antagon ...... tive pulmonary disease (COPD).
@en
P2093
P2860
P1476
Long-acting muscarinic antagon ...... ctive pulmonary disease (COPD)
@en
P2093
Atsushi Goto
Kenjiro Nagai
Kentaro Nakashima
Nobuyuki Horita
Takeshi Kaneko
Yuji Shibata
P2860
P304
P356
10.1002/14651858.CD012066.PUB2
P50
P577
2017-02-10T00:00:00Z